TETTAMANTI, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1.826
EU - Europa 1.458
AS - Asia 749
SA - Sud America 38
AF - Africa 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.089
Nazione #
US - Stati Uniti d'America 1.804
IT - Italia 524
SG - Singapore 293
RU - Federazione Russa 227
IE - Irlanda 187
CN - Cina 180
DE - Germania 178
SE - Svezia 112
HK - Hong Kong 95
ID - Indonesia 53
GB - Regno Unito 49
IN - India 39
FR - Francia 33
BR - Brasile 30
FI - Finlandia 26
CA - Canada 22
UA - Ucraina 19
NL - Olanda 18
PK - Pakistan 17
BE - Belgio 15
AT - Austria 14
DK - Danimarca 12
VN - Vietnam 12
JP - Giappone 10
TR - Turchia 10
CH - Svizzera 8
RO - Romania 8
IR - Iran 7
AU - Australia 5
CZ - Repubblica Ceca 5
ES - Italia 5
PH - Filippine 5
TW - Taiwan 5
IL - Israele 4
KR - Corea 4
NO - Norvegia 4
PL - Polonia 4
RS - Serbia 4
BD - Bangladesh 3
EG - Egitto 3
IQ - Iraq 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
AM - Armenia 2
BO - Bolivia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CO - Colombia 1
DZ - Algeria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.089
Città #
Ann Arbor 429
Singapore 213
Chandler 186
Dublin 181
Milan 161
Frankfurt am Main 117
Fairfield 114
Ashburn 106
Hong Kong 92
Wilmington 78
Seattle 74
Woodbridge 62
New York 57
Houston 51
Jakarta 48
Cambridge 47
Santa Clara 46
Shanghai 45
Bergamo 39
Princeton 37
Dearborn 28
Lissone 22
Nanjing 21
Moscow 20
Altamura 15
Brussels 15
Helsinki 14
Hefei 13
Lawrence 13
Monza 13
Borgomanero 11
Jacksonville 11
Carate Brianza 10
Carrboro 10
Council Bluffs 10
Dallas 10
Hyderabad 10
Seregno 10
Chicago 9
Lahore 9
Munich 9
Paris 9
Turin 9
Andover 8
Bologna 8
Cinisello Balsamo 8
Fremont 8
Rome 8
Tokyo 8
Vienna 8
Beijing 7
Desio 7
Hangzhou 7
Los Angeles 7
Nuremberg 7
Toronto 7
Denver 6
Düsseldorf 6
Galliate 6
London 6
Missaglia 6
Ottawa 6
Contursi 5
Edmonton 5
Ferrara 5
Islamabad 5
Jinan 5
Lappeenranta 5
Manchester 5
Naples 5
Pioltello 5
Pune 5
Caronno Pertusella 4
Changsha 4
Durham 4
Florence 4
Genoa 4
Isfahan 4
Mumbai 4
Newark 4
Pieve Emanuele 4
Ponte San Pietro 4
Portsmouth 4
San Diego 4
Stockholm 4
The Dalles 4
Turku 4
Zhengzhou 4
Amstelveen 3
Bergen 3
Boardman 3
Boston 3
Brescia 3
Brno 3
Castano Primo 3
Cerreto Guidi 3
Chapel Hill 3
Delhi 3
Dhaka 3
Guangzhou 3
Totale 2.768
Nome #
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 312
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 280
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 275
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 269
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 266
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 250
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 225
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 190
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 153
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 152
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 149
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 137
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 136
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 132
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use 132
Catch me if you can: how AML and its niche escape immunotherapy 127
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 121
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 118
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 115
CARs are sharpening their weapons 107
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 103
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 97
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 81
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 72
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 71
Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions 71
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 63
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab 30
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies 27
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 14
Totale 4.275
Categoria #
all - tutte 16.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 12 22
2020/2021627 20 72 136 55 51 62 39 46 33 43 29 41
2021/2022335 23 33 22 18 20 18 11 15 24 32 24 95
2022/2023703 91 164 69 65 16 93 19 51 49 4 58 24
2023/2024723 31 29 45 59 72 171 117 46 59 19 14 61
2024/20251.342 62 111 134 65 109 103 125 74 150 247 162 0
Totale 4.275